Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 2
2022 2
2023 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
Jillson LK, Yette GA, Laajala TD, Tilley WD, Costello JC, Cramer SD. Jillson LK, et al. Cancers (Basel). 2021 Jun 30;13(13):3272. doi: 10.3390/cancers13133272. Cancers (Basel). 2021. PMID: 34208794 Free PMC article. Review.
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Romano G, Paradiso F, Li P, Shukla P, Barger LN, El Naggar O, Miller JP, Liang RJ, Helms TL, Lazar AJ, Wargo JA, Taraballi F, Costello JC, Kwong LN. Romano G, et al. Cancer Immunol Res. 2023 May 3;11(5):558-569. doi: 10.1158/2326-6066.CIR-22-0224. Cancer Immunol Res. 2023. PMID: 36820825 Free PMC article.
curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.
Laajala TD, Sreekanth V, Soupir A, Creed J, Calboli FC, Singaravelu K, Orman M, Colin-Leitzinger C, Gerke T, Fidley BL, Tyekucheva S, Costello JC. Laajala TD, et al. bioRxiv [Preprint]. 2023 Jan 19:2023.01.17.524403. doi: 10.1101/2023.01.17.524403. bioRxiv. 2023. Update in: Sci Data. 2023 Jul 5;10(1):430. doi: 10.1038/s41597-023-02335-4 PMID: 36711769 Free PMC article. Updated. Preprint.
MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.
Jillson LK, Rider LC, Rodrigues LU, Romero L, Karimpour-Fard A, Nieto C, Gillette C, Torkko K, Danis E, Smith EE, Nolley R, Peehl DM, Lucia MS, Costello JC, Cramer SD. Jillson LK, et al. Mol Cancer Res. 2021 Jul;19(7):1123-1136. doi: 10.1158/1541-7786.MCR-20-0913. Epub 2021 Apr 12. Mol Cancer Res. 2021. PMID: 33846123 Free PMC article.
12 results